Here's good news for anyone trying to lose weight or has osteoporosis: Scientists from Maine are on the trail of a weight loss drug that may revolutionize how we treat these ...

Patients suffering with heart failure are more likely to die if they have high levels of a bone hormone called osteoprotegerin (OPG). That is the finding of a research team ...

Due to a fairly high percentage (12-13%) of five year revision or secondary hip surgeries DePuy Orthopaedics, Inc. reported based on this year's data from the National Joint ...

Researchers at New York University have developed an innovative way to look at the development of osteoarthritis in the knee joint - one that relies on the examination of ...

Plenary lectures enhanced by meet-the-expert sessions, orthopaedic and diagnostic roundtables Clinicians, researchers and allied health professionals with an interest in ...

Scientists in Germany have found a gene mutation implicated in Mabry Symdrome, a rare genetic disease that causes mental retardation; they used a new process that analyzes ...

CareFusion (NYSE: CFN), a leading, global medical device company, announced the national commercial launch of the AVAmax® Vertebral Balloon, a minimally invasive device ...

South Korea-based Medyssey Co., Ltd. announced that the Company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Zenius(TM) Thoracolumbar ...

The recent ruling by federal judge Royce C. Lamberth halting embryonic stem cell research may present a hurdle for some disease research but not necessarily for arthriti...

The International Osteoporosis Foundation (IOF) celebrated the opening of its new regional office for the Asia Pacific region, in Singapore. The well attended media event ...